AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $202,000 | -22.6% | 7,509 | -8.3% | 0.00% | -50.0% |
| Q1 2018 | $261,000 | -7.4% | 8,190 | +9.8% | 0.00% | 0.0% |
| Q4 2017 | $282,000 | +872.4% | 7,456 | +180.5% | 0.00% | – |
| Q2 2016 | $29,000 | +38.1% | 2,658 | +70.8% | 0.00% | – |
| Q1 2016 | $21,000 | 0.0% | 1,556 | +33.6% | 0.00% | – |
| Q4 2015 | $21,000 | – | 1,165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|